-
摘要: 目的 探讨单孔机器人辅助单纯前列腺切除术(spRASP)治疗良性前列腺增生(BPH)的可行性及临床应用价值。方法 回顾性分析2020年11月—2021年6月上海中医药大学附属曙光医院泌尿中心7例采用spRASP治疗BPH患者的临床资料。平均年龄(67±9)岁。经估算的平均前列腺体积(78.3±12.9) mL; 平均残余尿(PVR)(58.0±24.8) mL; 平均国际前列腺症状评分(IPSS)(20.9±5.9)分,平均生活质量评分(QOL)(4.7±1.5)分,平均最大尿流率(Qmax)(7.9±3.6) mL/s。比较患者术前和术后3个月的IPSS评分、QOL评分、PVR、Qmax、IIEF等差异,分析评价手术疗效。结果 7例手术均顺利完成。平均手术时间(85.5±25.5) min,平均估计出血量(75.5±25.5) mL,平均留置引流管时间(3.4±0.8) d,平均留置尿管时间(7.5±1.2) d,术后平均住院时间(5.1±3.1) d。术后3个月患者平均IPSS评分(10.8±3.1)分、平均QOL评分(1.6±0.9)分、平均PVR(15.3±4.6) mL,与术前比较均明显降低(P < 0.05),平均Qmax(24.4±11.6) mL/s与术前比较明显升高(P < 0.05),IIEF与术前比较差异无统计学意义(P>0.05)。结论 spRASP是治疗BPH患者安全、有效的方法。Abstract: Objectives To assess the feasibility and efficacy of single-port robot assisted simple prostatectomy (spRASP) for the treatment of benign prostatic hyperplasia (BPH).Methods From November 2020 to June 2021, 7 patients with BPH were treated by spRASP in the urology center of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. The average patients' age was (67±9) years. The estimated prostate volume was (78.3±12.9) mL; preoperative residual urine volume was (58.0±24.8) mL; the average International Prostate Symptoms Score (IPSS) was (20.9±5.9) scores, the average Quality of Life Score (QOL) was (4.7±1.5) scores, the average maximum urine flow rate (Qmax) was (7.9±3.6) mL/s, respectively. All patients agreed to accept spRASP. The pre-operative and three months post-operative IPSS, QOL, residual urine and Qmax were compared and analyzed.Results All seven patients were successfully completed. The average operation time was (85.5±25.5) min, the average estimated blood loss was (75.5±25.5) mL, drainage time was (3.4±0.8) days, catheterization time was (7.5±1.2) days, postoperative hospital stay was (5.1±3.1) days. Three months after surgery, patient' s IPSS was (10.8±3.1) scores, QOL was (1.6±0.9) scores, the average residual urine was (15.3±4.6) mL and Qmax was (24.4±11.6) mL/s, respectively. All the parameters significantly improved compared with the preoperative data (P < 0.05).Conclusion spRASP is a safe and effective treatment for patients with BPH.
-
Key words:
- robotic single-port surgery /
- laparoscope /
- Madigan /
- benign prostatic hyperplasia /
- prostatectomy
-
表 1 术前与术后3个月随访结果比较
X ± S 项目 术前 术后3个月 P值 PVR/mL 58.0±24.8 15.3±4.6 < 0.05 IPSS评分/分 20.9±5.9 10.8±3.1 < 0.05 QOL评分/分 4.7±1.5 1.6±0.9 < 0.05 Qmax/(mL·s-1) 7.9±3.6 24.4±11.6 < 0.05 IIEF 55.2±10.8 53.4±12.3 >0.05 -
[1] 王东文, 原小斌. 良性前列腺增生药物治疗的昨天、今天、明天[J]. 现代泌尿外科杂志, 2020, 25(2): 105-108. https://www.cnki.com.cn/Article/CJFDTOTAL-MNWK202002005.htm
[2] 张峻峰, 周彦, 杨正青, 等. HoLEP改良操作对尿失禁与性功能的影响分析[J]. 中国男科学杂志, 2021, 35(2): 46-49. https://www.cnki.com.cn/Article/CJFDTOTAL-NXXX202102010.htm
[3] Sotelo R, Clavijo R, Carmona O, et al. Robotic simple prostatectomy[J]. J Urol, 2008, 179(2): 513-515. doi: 10.1016/j.juro.2007.09.065
[4] Sorokin I, Sundaram V, Singla N, et al. Robot-Assisted Versus Open Simple Prostatectomy for Benign Prostatic Hyperplasia in Large Glands: A Propensity Score-Matched Comparison of Perioperative and Short-Term Outcomes[J]. J Endourol, 2017, 31(11): 1164-1169. doi: 10.1089/end.2017.0489
[5] Rowland D, McMahon CG, Abdo C, et al. Disorders of orgasm and ejaculation in men[J]. J Sex Med, 2010, 7(4 Pt 2): 1668-1686.
[6] Dixon AR, Lord PH, Madigan MR. The Madigan prostatectomy[J]. J Urol, 1990, 144(6): 1401-1403. doi: 10.1016/S0022-5347(17)39753-7
[7] Quan C, Chang W, Chen J, et al. Laparoscopic Madigan prostatectomy[J]. J Endourol, 2011, 25(12): 1879-1882. doi: 10.1089/end.2011.0117
[8] Wang P, Xia D, Ye S, et al. Robotic-assisted Urethra-sparing Simple Prostatectomy Via an Extraperitoneal Approach[J]. Urology, 2018, 119: 85-90. doi: 10.1016/j.urology.2018.06.005
[9] Cacciamani GE, Cuhna F, Tafuri A, et al. Anterograde ejaculation preservation after endoscopic treatments in patients with bladder outlet obstruction: systematic review and pooled-analysis of randomized clinical trials[J]. Minerva Urol Nefrol, 2019, 71(5): 427-434.
[10] De Nunzio C, Tabatabaei S, Tubaro A. Ejaculation disorders in prostate surgery[J]. Minerva Urol Nefrol, 2019, 71(5): 549-550.
[11] Marra G, Sturch P, Oderda M, et al. Systematic review of lower urinary tract symptoms/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: Time for a bespoke approach?[J]. Int J Urol, 2016, 23(1): 22-35. doi: 10.1111/iju.12866
[12] Gil-Vernet JM Jr, Alvarez-Vijande R, Gil-Vernet A, et al. Ejaculation in men: a dynamic endorectal ultrasonographical study[J]. Br J Urol, 1994, 73(4): 442-448. doi: 10.1111/j.1464-410X.1994.tb07612.x
[13] Sturch P, Woo HH, McNicholas T, et al. Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking?[J]. BJU Int, 2015, 115(2): 186-187. doi: 10.1111/bju.12868
[14] Lu J, Ye Z, Hu W. Modified madigan prostatectomy: a procedure preserved prostatic urethra intact[J]. J Huazhong Univ Sci Technolog Med Sci, 2005, 25(3): 323-325. doi: 10.1007/BF02828156
[15] Simone G, Misuraca L, Anceschi U, et al. Urethra and Ejaculation Preserving Robot-assisted Simple Prostatectomy: Near-infrared Fluorescence Imaging-guided Madigan Technique[J]. Eur Urol, 2019, 75(3): 492-497. doi: 10.1016/j.eururo.2018.11.051
[16] 琚官群, 王志军, 时佳子, 等. 经腹膜外机器人单孔腹腔镜根治性前列腺切除术的初步应用[J]. 中华泌尿外科杂志, 2021, 42(1): 61-62.
[17] 时佳子, 王志军, 琚官群, 等. 机器人单孔腹腔镜根治性膀胱切除术的初步疗效分析(附9例报告)[J]. 中华泌尿外科杂志, 2020, 41(11): 811-814. doi: 10.3760/cma.j.cn112330-20200807-00586
[18] Porpiglia F, Checcucci E, Amparore D, et al. Urethral-sparing Robot-assisted Simple Prostatectomy: An Innovative Technique to Preserve Ejaculatory Function Overcoming the Limitation of the Standard Millin Approach[J]. Eur Urol, 2021, 80(2): 222-233. doi: 10.1016/j.eururo.2020.09.028
[19] 洪谦, 张志强, 张志辉, 等. 荧光辅助腹腔镜Madigan术治疗良性前列腺增生疗效分析[J]. 临床泌尿外科杂志, 2020, 35(5): 385-388. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202005013.htm